Target intelligence / Profile preview

Long intergenic non-protein coding RNA 2290 (LINC02290)

Target
LINC02290
Molecular classification
Long non-coding RNA, Long intergenic non-coding RNA (lincRNA), Non-coding RNA
01

Overview

LINC02290, officially termed Long intergenic non-protein coding RNA 2290, is a human gene that produces a long intergenic non-protein coding RNA[1]. LINC02290 belongs to the **long intergenic non-coding RNA (lincRNA)** class, which are RNAs longer than 200 nucleotides that do not overlap with protein-coding regions[3]. This class of RNA is widely involved in regulating gene expression by modulating chromatin structure, controlling transcription, stabilizing RNA, and in some cases, acting through enhancer-like mechanisms[3][5]. While the general class of lincRNAs has important regulatory roles—sometimes impacting cell proliferation, apoptosis, and cancer—the specific molecular function, disease relevance, and therapeutic value of LINC02290 itself have not been established in available scientific or biomedical literature. There are no known approved drugs, clinical biomarkers, or safety issues directly linked to LINC02290 at this time[1].

Other names
LINC02290
02

Biological functions

Regulation of gene expressionChromatin remodelingTranscription modulationRNA stabilizationPotential enhancer-associated activity
03

Disease associations

Other (no confirmed, specific role reported in major diseases; some lincRNAs have general associations with cancer and development, but no disease association reported for LINC02290 in available data)

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 2290 (LINC02290).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 2290 (LINC02290).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call